Cipla Ltd.

Cipla is currently trading at Rs. 918.85, up by 33.65 points or 3.80% from its previous closing of Rs. 885.20 on the BSE.

The scrip opened at Rs. 900.00 and has touched a high and low of Rs. 925.15 and Rs. 882.60 respectively. So far 306240 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 940.00 on 12-Apr-2021 and a 52 week low of Rs. 565.90 on 15-May-2020.

Last one week high and low of the scrip stood at Rs. 940.00 and Rs. 836.75 respectively. The current market cap of the company is Rs. 74319.62 crore.

The promoters holding in the company stood at 36.70%, while Institutions and Non-Institutions held 40.05% and 23.25% respectively.

Cipla has doubled production of COVID-19 medication remdesivir to help meet ‘unprecedented demand’ as the country battles a massive second wave of infections. India has overtaken Brazil as the world’s second-worst coronavirus-hit country after the United States, having administered about 107 million vaccine doses among a population of 1.4 billion.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.